This tender seeks information on a robust water systems solution for Onderstepoort Biological Products, focusing on the design and implementation of water storage systems for both potable and pharmaceutical-grade water. Key requirements include compliance with cGMP standards and a minimum reserve capacity.
Onderstepoort Biological Products SOC Ltd (OBP) is requesting information for a comprehensive water systems solution to support its vaccine manufacturing operations. The facility requires a reliable Water Holding and Storage System that can ensure continuous production during municipal water shortages. The solution must accommodate two distinct tiers of water: a bulk holding system for raw and potable water, and a pharmaceutical-grade holding system for Purified Water (PW) and Water for Injection (WFI). Vendors are invited to provide detailed proposals that include engineering designs, compliance with sanitary standards, and budgetary estimates for a turnkey solution.
The scope of work includes the design specifications for both potable bulk holding and pharmaceutical-grade storage, with a focus on ensuring a minimum reserve capacity of 500,000 to 1,000,000 liters for potable water and a 24- to 48-hour buffer for PW/WFI. Vendors must demonstrate their capability in previous installations within cGMP environments and provide technical system descriptions, including automation architecture for monitoring water quality. This project not only aims to enhance the operational efficiency of OBP but also ensures the integrity and safety of vaccine production, thereby contributing to public health and food security in South Africa.
This tender is suitable for engineering firms, water system manufacturers, and consultants with experience in pharmaceutical-grade water systems and cGMP compliance. Companies with a proven track record in designing and implementing water storage solutions for vaccine or biologics production are encouraged to apply.